Group One Trading, L.P. Amicus Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 15,629 shares of FOLD stock, worth $97,837. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,629

Holding current value

$97,837

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$8.16 - $9.85 $127,532 - $153,945	15,629 New	15,629 $127,000
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $202,241 - $294,538	20,285 Added 153.34%	33,514 $475,000
Q3 2023 Nov 09, 2023	BUY	$11.78 - $13.86 $155,837 - $183,353	13,229 New	13,229 $160,000
Q4 2022 Feb 09, 2023	BUY	$9.89 - $12.7 $181,610 - $233,210	18,363 Added 17.37%	124,051 $1.51 Million
Q3 2022 Nov 09, 2022	SELL	$9.82 - $12.75 $188,760 - $245,080	-19,222 Reduced 15.39%	105,688 $1.1 Million
Q2 2022 Aug 11, 2022	SELL	$6.23 - $11.12 $294,834 - $526,254	-47,325 Reduced 27.48%	124,910 $1.34 Million
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $238,806 - $377,732	30,267 Added 21.32%	172,235 $1.63 Million
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $25,099 - $31,796	2,556 Added 1.83%	141,968 $1.64 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $108,323 - $146,744	-12,394 Reduced 8.16%	139,412 $1.33 Million
Q2 2021 Aug 10, 2021	SELL	$8.71 - $10.72 $1.19 Million - $1.47 Million	-137,036 Reduced 47.44%	151,806 $1.46 Million
Q1 2021 May 12, 2021	BUY	$9.2 - $23.86 $1.84 Million - $4.77 Million	199,876 Added 224.67%	288,842 $2.85 Million
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $119,707 - $221,197	-8,887 Reduced 9.08%	88,966 $2.05 Million
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $1.26 Million - $1.55 Million	97,853 New	97,853 $1.38 Million
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $788,531 - $1.4 Million	-88,999 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$6.63 - $11.16 $390,632 - $657,536	58,919 Added 195.87%	88,999 $822,000
Q4 2019 Feb 10, 2020	BUY	$7.48 - $10.75 $165,816 - $238,306	22,168 Added 280.18%	30,080 $293,000
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $8,733 - $14,429	1,089 Added 15.96%	7,912 $63,000
Q2 2019 Aug 09, 2019	BUY	$10.96 - $14.4 $74,780 - $98,251	6,823 New	6,823 $85,000
Q1 2019 May 13, 2019	SELL	$10.04 - $13.92 $563,766 - $781,635	-56,152 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$8.38 - $13.44 $411,835 - $660,508	49,145 Added 701.37%	56,152 $538,000
Q3 2018 Nov 08, 2018	SELL	$11.6 - $16.54 $680,653 - $970,517	-58,677 Reduced 89.33%	7,007 $85,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $882,769 - $1.15 Million	-67,233 Reduced 50.58%	65,684 $1.03 Million
Q1 2018 May 11, 2018	SELL	$13.76 - $17.12 $251,505 - $312,919	-18,278 Reduced 12.09%	132,917 $2 Million
Q4 2017 Feb 09, 2018	SELL	$12.51 - $16.24 $1.63 Million - $2.11 Million	-130,135 Reduced 46.26%	151,195 $2.18 Million
Q3 2017 Nov 15, 2017	BUY	$11.74 - $15.78 $3.3 Million - $4.44 Million	281,330	281,330 $4.24 Million

Others Institutions Holding FOLD

# of Institutions

315

Shares Held

319M

Call Options Held

378K

Put Options Held

575K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Amicus Therapeutics, Inc. Transaction History